|
Legaz I, Jimenez-Coll V, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos MJ, Galian JA, Botella C, Moya-Quiles R, Muro-Perez M, Minguela A, Llorente S, Muro M. MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. Biomedicines. 2024 Jan 5;12(1):116. doi: 10.3390/biomedicines12010116. PubMed PMID: 38255221; PubMed Central PMCID: PMC10813128.
AÑO: 2024; IF: 3.9
|
38255221
|
Pons-Fuster E, Bernal E, Guillamon CF, Gimeno L, Martinez-Sanchez MV, Ruiz-Lorente I, Campillo JA, Ceballos D, Torres A, Tomas C, Munoz A, Alcaraz A, Selma P, Ruiz-Nicolas C, Muro M, Minguela A. HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation. Infect Dis (Lond). 2024 Oct;56(10):818-829. doi: 10.1080/23744235.2024.2351047. Epub 2024 May 14. PubMed PMID: 38743055.
AÑO: 2024; IF: 2.3
|
|
Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, Campillo JA, Lopez-Hernandez R, Gonzalez-Lopez R, Otalora-Alcaraz A, Ortuno-Hernandez C, Gimeno L, Ruiz-Lorente I, Ceballos-Francisco D, Muro M, Martinez-Camblor P, Minguela A. Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases. Biomedicines. 2024 Oct 24;12(11):2439. doi: 10.3390/biomedicines12112439. PubMed PMID: 39595006; PubMed Central PMCID: PMC11592343.
AÑO: 2024; IF: 3.9
|
|
Botella C, Galian JA, Jimenez-Coll V, Fernandez-Gonzalez M, Morales F, Martinez-Gomez G, Gonzalez-Lopez R, Alegria MJ, Moya MR, Martinez-Banaclocha H, Minguela A, Legaz I, Llorente S, Muro M. Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center. Life (Basel). 2024 Nov 16;14(11):1491. doi: 10.3390/life14111491. PubMed PMID: 39598289; PubMed Central PMCID: PMC11595986.
AÑO: 2024; IF: 3.4
|
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2024 Jan;26(1):278-287. doi: 10.1007/s12094-023-03251-0. Epub 2023 Jun 27. PubMed PMID: 37368200.
AÑO: 2024; IF: 2.5
|